Therapeutic Advances in Urology — Journal Profile & Submission Links
SAGE Publishing · ISSN-L 1756-2872
Source-backed journal profile with OpenAlex metadata and links to official submission resources for Therapeutic Advances in Urology.
This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.
Official links
- Journal homepage
- us.sagepub.com/en-us/nam/journal/therapeutic-advances-urolog…
- Author guidelines
- journals.sagepub.com/author-instructions/tau
Catalog scope notes
Gold open access journal – all articles are made freely available online immediately upon publication Listed in PubMed and indexed in Web of Science, Science Citation Index Expanded (SCIE) and Scopus Over 200,000 full-text article views annually Therapeutic Advances in Urology (TAU) is a peer-reviewed open access journal delivering the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology. Please see the Aims and Scope for further information. This journal is a member of the Committee on Publication Ethics (COPE). This journal flipped to open access on January 1, 2019. Diversity, Equity and Inclusion Statement Therapeutic Advances in Urology (TAU) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the urology community. Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives. We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status. We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms. Submit your manuscript today at http://mc.manuscriptcentral.com/tau. Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence. The APC for this journal is currently $3,200 USD. The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is also subject to taxes where applicable. Please see further details here. Click here to meet the Editorial Team of Therapeutic Advances in Urology (TAU). Please direct any queries to urology@sagepub.co.uk. Therapeutic Advances in Urology delivers the highest quality peer-reviewed, open access, original research articles, reviews, and scholarly comment on pioneering efforts across all areas of urology.
Catalog source: scimago. This is not a copy of the publisher's author instructions.
Submission & timeline
- Submission portal
- Information not currently available.
- Average review time
- Information not currently available.
- Acceptance rate
- Information not currently available.
- Article types accepted
- Information not currently available.
- Publication frequency
- Information not currently available.
General pre-submission checks for medical manuscripts
Generic checklist only — not journal-specific requirements.
- Confirm scope fit and intended article type on the official journal site.
- Abstract structure matches the journal's current requirements.
- Ethics approval and trial registration statements are complete.
- Informed consent and patient privacy statements are in place.
- Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
- Reference style and citation limits per official guidelines.
- Figures and tables meet resolution, labeling, and count limits.
- Cover letter addresses novelty, fit, and required declarations.
- Conflicts of interest statement included.
- Funding statement included.
- Data availability statement included when required.